The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of dose modifications on response to duvelisib in patients with relapsed/refractory (R/R) CLL/SLL in the DUO trial.
 
Ian Flinn
Consulting or Advisory Role - Abbvie (Inst); Seagen (Inst); TG Therapeutics (Inst); Verastem (Inst)
Research Funding - Abbvie (Inst); Abbvie (Inst); Acerta Pharma (Inst); Agios (Inst); ArQule (Inst); AstraZeneca (Inst); BeiGene (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Curis (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Juno Therapeutics (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Merck (Inst); MorphoSys (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Takeda (Inst); Teva (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst); Unum Therapeutics (Inst); Verastem (Inst)
 
Marco Montillo
Honoraria - Abbvie; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; Gilead Sciences; Janssen
 
Árpád Illés
Research Funding - Abbvie (Inst); Novartis (Inst); Roche (Inst)
 
Gabriel Etienne
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Julio Delgado
No Relationships to Disclose
 
Bryone J. Kuss
Honoraria - Abbvie; Gilead Sciences; Janssen; Merck; Mundipharma; Roche; Takeda
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; Merck; Mundipharma; Roche; Takeda
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Constantine Si Lun Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Janssen-Cilag (Inst)
 
Fritz Offner
No Relationships to Disclose
 
Francesc Bosch
Honoraria - Abbvie; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Gilead Sciences; Janssen; Novartis; Roche
Research Funding - Abbvie; AstraZeneca; Gilead Sciences; Janssen; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Gilead Sciences; Janssen; Novartis; Roche
 
Matthew Steven Davids
Consulting or Advisory Role - Abbvie; Acerta Pharma; Adaptive Biotechnologies; AstraZeneca; Celgene; Genentech; Gilead Sciences; Janssen; MEI Pharma; Merck; Pharmacyclics; Roche; Syros Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Surface Oncology (Inst); TG Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Ulrich Jäger
Honoraria - Abbvie; Amgen; AOP Orphan Pharmaceuticals; Bioverativ; Bristol-Myers Squibb; Celgene; Emergent BioSolutions; Gilead Sciences; Janssen-Cilag; Mundipharma; Novartis; Roche; Sandoz; Takeda; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Research Funding - Abbvie (Inst); Bioverativ (Inst); Celgene (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen-Cilag (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Paolo Ghia
Honoraria - Abbvie; AstraZeneca; BeiGene; Celgene; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Celgene; Gilead Sciences; Janssen; Sunesis Pharmaceuticals
Speakers' Bureau - Gilead Sciences
Research Funding - Abbvie; Gilead Sciences; Janssen; Novartis; Sunesis Pharmaceuticals
 
Florence Cymbalista
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie
Research Funding - Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; Roche
 
David T. Weaver
Employment - Agios (I); Verastem
Stock and Other Ownership Interests - Agios (I); FemtoDX; Nanogen Biopharmaceutical; Verastem
Consulting or Advisory Role - FemtoDX; Nanogen Biopharmaceutical
Patents, Royalties, Other Intellectual Property - Patent Agios (I); Patent Ovascience; Patent Verastem
 
Stephanie Lustgarten
Employment - ARIAD/Takeda; Verastem
Stock and Other Ownership Interests - ARIAD/Takeda; Verastem
 
Hagop Youssoufian
Employment - BIND Therapeutics
Stock and Other Ownership Interests - Verastem
Consulting or Advisory Role - Verastem
Travel, Accommodations, Expenses - Verastem
 
Stephan Stilgenbauer
Honoraria - AbbVie, AstraZeneca, Celgene, Gilead, GSK, Hoffmann La-Roche, Janssen,
Consulting or Advisory Role - AbbVie, AstraZeneca, Celgene, Gilead, GSK, Hoffmann La-Roche, Janssen,
Speakers' Bureau - AbbVie, AstraZeneca, Celgene, Gilead, GSK, Hoffmann La-Roche, Janssen,
Research Funding - AbbVie, AstraZeneca, Celgene, Gilead, GSK, Hoffmann La-Roche, Janssen,
Travel, Accommodations, Expenses - AbbVie, AstraZeneca, Celgene, Gilead, GSK, Hoffmann La-Roche, Janssen,
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; pharmacyclics; ProNAi; Roche
Research Funding - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); AstraZeneca (Inst); Beigene (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Juno Therapeutics (Inst); Loxo (Inst); ProNAi (Inst); TG Therapeutics (Inst); Verastem (Inst)